alpha-1 treatment - Yahoo Search Results

Ads
related to: alpha-1 treatment
Patient Screening For T1D - Learn More at HCP Site

t1dtreatment.com
Discuss the Importance of Familial Screening for T1D With Your Patients. See if this T1D Treatment is Right For Your Patients
Patient Criteria · Dosing Instructions · Clinical Trial Data · Patient Support
Types: Screen Brochure, Copay & Enrollment, Patient Start Form, Support Communities
How To Screen For T1D
Learn How To Screen

Patients For T1D

Learn About T1D Treatment
Discover T1D Treatment for

Appropriate Patients

Patient Support
Discover Support For Patients

On Their T1D Journey

Familial Risk
Discover T1D Familial Risks

For Patients
Alpha-1 Deficiency Therapy - Learn About A Treatment Option

www.treatalpha1.com
Learn More About ATS Screening Guidelines And A Treatment For Alpha-1. Learn About A Test That Detects Alpha-1 In COPD Patients. Visit The Site To Order A Kit.
Order A Test Kit
View An Alpha-1 Treatment
Learn About Diagnosing
View Physician Resources

Search results

- Is it a Good Idea to Invest in Intellia (NTLA) Stock Now?
  Zacks via Yahoo Finance· 5 months ago
  Intellia Therapeutics, Inc. NTLA is a clinical-stage genome editing company focused on developing...
- Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
  Motley Fool· 6 months ago
  Vertex Pharmaceuticals (NASDAQ: VRTX) has built a billion-dollar cystic fibrosis (CF) treatment...
- Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It
  Investor's Business Daily· 4 months ago
  Sanofi is getting into the liver disease treatment space with its $1.7 billion acquisition of...
- The Zacks Analyst Blog Highlights bluebird, Editas Medicine, Beam Therapeutics and Intellia...
  Zacks via Yahoo Finance· 6 months ago
  For Immediate Release Chicago, IL – December 14, 2023 – Zacks.com announces the list of stocks...
- Vertex Moves Its Alpha-1 Antitrypsin Deficiency Program Forward
  Benzinga via Yahoo Finance· 2 years ago
  Vertex Pharmaceuticals Inc (NASDAQ: VRTX) has advanced its investigational program targeting alpha-1...
- Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease
  Investor's Business Daily· 2 years ago
  Arrowhead Pharmaceuticals has provided a bullish update for its midstage liver disease treatment,...
- These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?
  Motley Fool· 6 months ago
  On Nov. 3, Korro Bio (NASDAQ: KRRO) used Frequency Therapeutics' Nasdaq listing to reverse merge...
- CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
  Investor's Business Daily· 2 years ago
  A cure for genetic diseases has been little more than a whisper — until now. Thanks to the work of...
- A new non-surgical procedure is helping those with emphysema breathe better. The only problem? Not...
  USA TODAY via Yahoo News· 2 years ago
  MILWAUKEE — About two years ago, John McLees' lungs had become so badly damaged that he could barely...
- Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why
  Zacks via Yahoo Finance· 2 weeks ago
  Shares of the commercial-stage biotechnology company, Krystal Biotech, Inc. KRYS, surged 36.5% year...